$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Cyclodextrin-based supramolecular systems for drug delivery: Recent progress and future perspective 원문보기

Advanced drug delivery reviews, v.65 no.9, 2013년, pp.1215 - 1233  

Zhang, J. ,  Ma, P.X.

Abstract AI-Helper 아이콘AI-Helper

The excellent biocompatibility and unique inclusion capability as well as powerful functionalization capacity of cyclodextrins and their derivatives make them especially attractive for engineering novel functional materials for biomedical applications. There has been increasing interest recently to ...

주제어

참고문헌 (216)

  1. C. R. Acad. Sci. Villiers 112 536 1891 Sur la fermentation de la fe cule par l'action du ferment butyrique 

  2. Chem. Rev. Li 92 1457 1992 10.1021/cr00014a009 Cyclodextrins and their applications in analytical chemistry 

  3. Angew. Chem. Int. Ed. Saenger 19 344 1980 10.1002/anie.198003441 Cyclodextrin inclusion compounds in research and industry 

  4. Chem. Rev. Villalonga 107 3088 2007 10.1021/cr050253g Supramolecular chemistry of cyclodextrins in enzyme technology 

  5. Chem. Rev. Takahashi 98 2013 1998 10.1021/cr9700235 Organic reactions mediated by cyclodextrins 

  6. Chem. Rev. Uekama 98 2045 1998 10.1021/cr970025p Cyclodextrin drug carrier systems 

  7. Chem. Rev. Breslow 98 1997 1998 10.1021/cr970011j Biomimetic reactions catalyzed by cyclodextrins and their derivatives 

  8. Chem. Rev. Lipkowitz 98 1829 1998 10.1021/cr9700179 Applications of computational chemistry to the study of cyclodextrins 

  9. Biotechnol. Adv. Singh 20 341 2002 10.1016/S0734-9750(02)00020-4 Biotechnological applications of cyclodextrins 

  10. Nat. Rev. Drug Discov. Davis 3 1023 2004 10.1038/nrd1576 Cyclodextrin-based pharmaceutics: past, present, and future 

  11. Chem. Rev. Rekharsky 98 1875 1998 10.1021/cr970015o Complexation thermodynamics of cyclodextrins 

  12. Angew. Chem. Int. Ed. Fuchs 32 852 1993 10.1002/anie.199308521 Multinuclear sandwich-type complexes of deprotonated β-cyclodextrin and copper(II) ions 

  13. Adv. Drug Deliv. Rev. Irie 36 101 1999 10.1016/S0169-409X(98)00057-X Cyclodextrins in peptide and protein delivery 

  14. J. Pharm. Sci. Lysik 92 1559 2003 10.1002/jps.10399 Innovations in oligonucleotide drug delivery 

  15. J. Pharm. Sci. Irie 86 147 1997 10.1021/js960213f Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation 

  16. Adv. Drug Deliv. Rev. Brewster 59 645 2007 10.1016/j.addr.2007.05.012 Cyclodextrins as pharmaceutical solubilizers 

  17. J. Control. Release Carrier 123 78 2007 10.1016/j.jconrel.2007.07.018 The utility of cyclodextrins for enhancing oral bioavailability 

  18. Adv. Drug Deliv. Rev. Hirayama 36 125 1999 10.1016/S0169-409X(98)00058-1 Cyclodextrin-based controlled drug release system 

  19. J. Pharm. Pharmacol. Loftsson 63 1119 2011 10.1111/j.2042-7158.2011.01279.x Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes 

  20. Adv. Drug Deliv. Rev. Matsuda 36 80 1999 10.1016/S0169-409X(98)00056-8 Cyclodextrins in transdermal and rectal delivery 

  21. Adv. Drug Deliv. Rev. Loftsson 36 59 1999 10.1016/S0169-409X(98)00055-6 Cyclodextrins in ophthalmic drug delivery 

  22. Adv. Drug Deliv. Rev. Merkus 36 41 1999 10.1016/S0169-409X(98)00054-4 Cyclodextrins in nasal drug delivery 

  23. Adv. Drug Deliv. Rev. Szente 36 17 1999 10.1016/S0169-409X(98)00092-1 Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development 

  24. Adv. Drug Deliv. Rev. Duchene 36 29 1999 10.1016/S0169-409X(98)00053-2 Cyclodextrins in targeting application to nanoparticles 

  25. Pharm. Technol. Sinha 44 36 2002 Cyclodextrins as sustained-release carriers 

  26. Int. J. Pharm. Loftsson 329 1 2007 10.1016/j.ijpharm.2006.10.044 Cyclodextrins and their pharmaceutical applications 

  27. Acc. Chem. Res. Harada 34 456 2001 10.1021/ar000174l Cyclodextrin-based molecular machines 

  28. Soft Matter Araki 3 1456 2007 10.1039/b705688e Recent advances in the preparation of cyclodextrin-based polyrotaxanes and their applications to soft materials 

  29. Adv. Drug Deliv. Rev. Li 60 1000 2008 10.1016/j.addr.2008.02.011 Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery 

  30. Soft Matter Yuen 6 4613 2010 10.1039/c0sm00043d Cyclodextrin-assisted assembly of stimuli-responsive polymers in aqueous media 

  31. J. Am. Chem. Soc. Ferris 131 1686 2009 10.1021/ja807798g Light-operated mechanized nanoparticles 

  32. J. Am. Chem. Soc. Liu 131 15128 2009 10.1021/ja905288m Multiresponsive supramolecular nanogated ensembles 

  33. Adv. Polym. Sci. Harada 201 1 2006 10.1007/12_056 Cyclodextrin-based supramolecular polymers 

  34. Adv. Polym. Sci. Li 222 79 2009 Cyclodextrin inclusion polymers forming hydrogels 

  35. Nano Today Zhang 5 337 2010 10.1016/j.nantod.2010.06.011 Host-guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications 

  36. Biomacromolecules van de Manakker 10 3157 2009 10.1021/bm901065f Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications 

  37. Polym. Chem. Zhou 1 1552 2010 10.1039/c0py00219d Cyclodextrin functionalized polymers as drug delivery systems 

  38. Adv. Polym. Sci. Yui 222 55 2009 Functional cyclodextrin polyrotaxanes for drug delivery 

  39. Chem. Soc. Rev. Mellet 40 1586 2011 10.1039/C0CS00019A Cyclodextrin-based gene delivery systems 

  40. Eur. J. Org. Chem. Sallas 957 2008 10.1002/ejoc.200700933 Amphiphilic cyclodextrins-advances in synthesis and supramolecular chemistry 

  41. Tetrahedron Lett. Zhang 32 2769 1991 10.1016/0040-4039(91)85081-F Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face 

  42. J. Phys. Org. Chem. Zhang 5 518 1992 10.1002/poc.610050814 Self-organizing systems based on amphiphilic cyclodextrin diesters 

  43. Langmuir Tchoreloff 11 191 1995 10.1021/la00001a033 Amphiphilic monolayers of insoluble cyclodextrins at the water/air interface. surface pressure and surface potential studies 

  44. J. Chem. Soc. Chem. Commun. Ling 438 1993 10.1039/C39930000438 Cyclodextrin liquid crystals: synthesis and self-organisation of amphiphilic thio-β-cyclodextrins 

  45. Langmuir Auzely-Velty 16 3727 2000 10.1021/la991361z Micellization of hydrophobically modified cyclodextrins. 1. Micellar structure 

  46. Langmuir Wang 27 91 2011 10.1021/la103288j Structural characterization of micelles formed of cholesteryl-functionalized cyclodextrins 

  47. Eur. J. Org. Chem. Mazzaglia 1715 2001 10.1002/1099-0690(200105)2001:9<1715::AID-EJOC1715>3.0.CO;2-A Novel amphiphilic cyclodextrins: graft-synthesis of heptakis(6-alkylthio-6-deoxy)-β-cyclodextrin 2-oligo(ethylene glycol) conjugates and their ω-halo derivatives 

  48. Langmuir Silva 24 3718 2008 10.1021/la702962f Synthesis and characterization of an amphiphilic cyclodextrin, a micelle with two recognition sites 

  49. Langmuir Nolan 19 4469 2003 10.1021/la034330j Preparation of vesicles and nanoparticles of amphiphilic cyclodextrins containing labile disulfide bonds 

  50. Org. Biomol. Chem. Mazzaglia 2 957 2004 10.1039/B400988F Multivalent binding of galactosylated cyclodextrin vesicles to lectin 

  51. Biomacromolecules McNicholas 8 1851 2007 10.1021/bm070055u Amphiphilic N-glycosyl-thiocarbamoyl cyclodextrins: synthesis, self-assembly, and fluorimetry of recognition by lens culinaris lectin 

  52. J. Am. Chem. Soc. Parrot-Lopez 114 5479 1992 10.1021/ja00039a100 Self-assembling systems of the amphiphilic cationic per-6-amino-β-cyclodextrin 2,3-Di-O-alkyl ethers 

  53. Chem. Commun. Donohue 2864 2002 10.1039/B207238F Cationic β-cyclodextrin bilayer vesicles 

  54. Chem. Eur. J. Mellet 16 6728 2010 10.1002/chem.201000076 Preorganized, macromolecular, gene-delivery systems 

  55. Chem. Eur. J. Diaz-Moscoso 15 12871 2009 10.1002/chem.200901149 Polycationic amphiphilic cyclodextrins for gene delivery: synthesis and effect of structural modifications on plasmid DNA complex stability, cytotoxicity, and gene expression 

  56. J. Org. Chem. Kraus 66 4595 2001 10.1021/jo010046q General approach to the synthesis of persubstituted hydrophilic and amphiphilic β-cyclodextrin derivatives 

  57. Tetrahedron Lett. Dubes 42 9147 2001 10.1016/S0040-4039(01)01992-X An efficient regio-specific synthetic route to multiply substituted acyl-sulphated β-cyclodextrins 

  58. Carbohydr. Res. Dubes 338 2185 2003 10.1016/S0008-6215(03)00356-2 Synthesis and characterisation of sulfated amphiphilic α-, β- and γ-cyclodextrins: application to the complexation of acyclovir 

  59. Chem. Commun. Sukegawa 430 2002 10.1039/b110673b Erythrocyte-like liposomes prepared by means of amphiphilic cyclodextrin sulfates 

  60. Adv. Mater. Zhang 23 3035 2011 10.1002/adma.201100679 Facile engineering of biocompatible materials with pH-modulated degradability 

  61. Biomaterials Chen 34 4159 2013 10.1016/j.biomaterials.2013.02.035 A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery 

  62. Biomaterials He 2013 10.1016/j.biomaterials.2013.03.068 Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel 

  63. Helv. Chim. Acta Solms 48 1225 1965 10.1002/hlca.19650480603 Harze mit einschlusshohlrhumen von cyclodextrin-struktur 

  64. Macromol. Symp. Renard 122 229 1997 10.1002/masy.19971220136 Polycondensation of cyclodextrins with epichlorohydrin. Influence of reaction conditions on the polymer structure 

  65. Eur. Polym. J. Renard 33 49 1997 10.1016/S0014-3057(96)00123-1 Preparation and characterization of water soluble high molecular weight β-cyclodextrin-epichlorohydrin polymers 

  66. Macromol. Rapid Commun. Guan 28 2244 2007 10.1002/marc.200700505 Novel anti-microbial host-guest complexes based on cationic β-cyclodextrin polymers and triclosan/butylparaben 

  67. Angew. Chem. Int. Ed. Smith 48 8974 2009 10.1002/anie.200902782 Layer-by-layer platform technology for small-molecule delivery 

  68. Biomacromolecules Daoud-Mahammed 10 547 2009 10.1021/bm801206f Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen 

  69. Colloids Surf. A Gosselet 155 177 1999 10.1016/S0927-7757(99)00026-6 Association of hydrophobically modified poly(N, N-dimethylacrylamide hydroxyethylmethacrylate) with water soluble β-cyclodextrin polymers 

  70. Macromol. Biosci. Yallapu 10 1141 2010 10.1002/mabi.201000084 Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells 

  71. Polymer Fagui 52 3752 2011 10.1016/j.polymer.2011.06.043 Well-defined core-shell nanoparticles containing cyclodextrin in the shell: a comprehensive study 

  72. J. Control. Release Gref 111 316 2006 10.1016/j.jconrel.2005.12.025 New self-assembled nanogels based on host-guest interactions: characterization and drug loading 

  73. Biomacromolecules Wintgens 13 528 2012 10.1021/bm201608n Cyclodextrin polymer nanoassemblies: strategies for stability improvement 

  74. J. Biomed. Mater. Res. Daoud-Mahammed 86A 736 2008 10.1002/jbm.a.31674 Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs 

  75. Bioconjugate Chem. Cheng 14 1007 2003 10.1021/bc0340924 Synthesis of linear, β-cyclodextrin-based polymers and their camptothecin conjugates 

  76. Bioconjugate Chem. Gonzalez 10 1068 1999 10.1021/bc990072j New class of polymers for the delivery of macromolecular therapeutics 

  77. Bioconjugate Chem. Popielarski 14 672 2003 10.1021/bc034010b Structural effects of carbohydrate-containing polycations on gene delivery. 3. Cyclodextrin type and functionalization 

  78. Mol. Pharmaceutics Davis 6 659 2009 10.1021/mp900015y The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic 

  79. Biomaterials Srinivasachari 30 928 2009 10.1016/j.biomaterials.2008.09.067 Versatile supramolecular pDNA vehicles via “click polymerization” of β-cyclodextrin with oligoethyleneamines 

  80. Chem. Commun. Huang 2382 2006 10.1039/B601130F Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-b-cyclodextrin or (2-hydroxypropyl)-c-cyclodextrin 

  81. J. Gene Med. Tang 8 736 2006 10.1002/jgm.874 Low molecular weight polyethylenimines linked by β-cyclodextrin for gene transfer into the nervous system 

  82. Biomaterials Huang 31 1830 2010 10.1016/j.biomaterials.2009.11.012 Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector 

  83. Bioconjugate Chem. Lu 21 1855 2010 10.1021/bc1002136 Bifunctional conjugates comprising β-cyclodextrin, polyethylenimine, and 5-fluoro-2′-deoxyuridine for drug delivery and gene transfer 

  84. Biomaterials Lu 32 4849 2011 10.1016/j.biomaterials.2011.03.022 A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors 

  85. Biomacromolecules Gou 11 934 2010 10.1021/bm901371p Synthesis, self-assembly, and drug-loading capacity of well-defined cyclodextrin-centered drug-conjugated amphiphilic A(14)B(7) miktoarm star copolymers based on poly(epsilon-caprolactone) and poly(ethylene glycol) 

  86. J. Polym. Sci. Part A: Polym. Chem. Gou 48 2961 2010 10.1002/pola.24066 Synthesis and self-assembly of well-defined cyclodextrin-centered amphiphilic A(14)B(7) multimiktoarm star copolymers based on poly(epsilon-caprolactone) and poly(acrylic acid) 

  87. Eur. Polym. J. Adeli 44 1921 2008 10.1016/j.eurpolymj.2008.03.028 Amphiphilic star copolymers containing cyclodextrin core and their application as nanocarrier 

  88. Chem. Eur. J. Mourtzis 14 4188 2008 10.1002/chem.200701650 Synthesis, characterization, and remarkable biological properties of cyclodextrins bearing guanidinoalkylamino and aminoalkylamino groups on their primary side 

  89. J. Am. Chem. Soc. Srinivasachari 130 4618 2008 10.1021/ja074597v Polycationic β-cyclodextrin “click clusters”: monodisperse and versatile scaffolds for nucleic acid delivery 

  90. Bioconjugate Chem. Bryson 19 1505 2008 10.1021/bc800200q A β-cyclodextrin “click cluster” decorated with seven paramagnetic chelates containing two water exchange sites 

  91. Macromolecules Harada 9 701 1976 10.1021/ma60053a003 Cyclodextrin-containing polymers. 1. Preparation of polymers 

  92. Macromolecules Munteanu 41 9619 2008 10.1021/ma8018975 Cyclodextrin methacrylate via microwave-assisted click reaction 

  93. Macromol. Biosci. Liu 3 715 2003 10.1002/mabi.200300052 Synthesis and characterization of β-cyclodextrin based functional monomers and its copolymers with N-isopropylacrylamide 

  94. Macromolecules Liu 43 10221 2010 10.1021/ma1019973 Star polymers with both temperature sensitivity and inclusion functionalities 

  95. J. Am. Chem. Soc. Wang 128 3703 2006 10.1021/ja056775v Polymeric self-assembly into micelles and hollow spheres with multiscale cavities driven by inclusion complexation 

  96. Macromol. Rapid Commun. Weickenmeier 17 731 1996 10.1002/marc.1996.030171008 Cyclodextrin sidechain polyesters - synthesis and inclusion of adamantan derivatives 

  97. Macromolecules Charlot 40 1147 2007 10.1021/ma062322e Synthesis of novel supramolecular assemblies based on hyaluronic acid derivatives bearing bivalent β-cyclodextrin and adamantane moieties 

  98. Angew. Chem. Int. Ed. Zhang 48 964 2009 10.1002/anie.200804135 Polymeric core-shell assemblies mediated by host-guest interactions: versatile nanocarriers for drug delivery 

  99. Macromol. Rapid Commun. Zhang 33 664 2012 10.1002/marc.201100814 Synthesis of β-cyclodextrin containing copolymer via “click” chemistry and its self-assembly in the presence of guest compounds 

  100. J. Polym. Sci. Polym. Lett. Ed. Ogata 14 459 1976 10.1002/pol.1976.130140803 Novel synthesis of inclusion polyamides 

  101. Macromolecules Harada 23 2821 1990 10.1021/ma00212a039 Complex formation between poly(ethylene glycol) and α-cyclodextrin 

  102. Angew. Chem. Int. Ed. Wenz 31 197 1992 10.1002/anie.199201971 Threading cyclodextrin rings on polymer chains 

  103. Crit. Rev. Ther. Drug Carrier Syst. Ooya 16 289 1999 10.1615/CritRevTherDrugCarrierSyst.v16.i3.20 Polyrotaxanes: synthesis, structure, and potential in drug delivery 

  104. J. Biomater. Sci. Polym. Ed. Ooya 8 437 1997 10.1163/156856297X00371 Synthesis and characterization of biodegradable polyrotaxane as a novel supramolecular-structured drug carrier 

  105. Macromol. Chem. Phys. Ooya 199 2311 1998 10.1002/(SICI)1521-3935(19981001)199:10<2311::AID-MACP2311>3.0.CO;2-T Supramolecular dissociation of biodegradable polyrotaxanes by enzymatic terminal hydrolysis 

  106. J. Control. Release Ooya 58 251 1999 10.1016/S0168-3659(98)00163-1 Synthesis of theophylline-polyrotaxane conjugates and their drug release via supramolecular dissociation 

  107. J. Control. Release Moon 124 43 2007 10.1016/j.jconrel.2007.08.029 In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide 

  108. Ann. Rev. Biochem. Mellman 55 663 1986 10.1146/annurev.bi.55.070186.003311 Acidification of the endocytic and exocytic pathways 

  109. Adv. Drug Deliv. Rev. Saito 55 199 2003 10.1016/S0169-409X(02)00179-5 Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities 

  110. Expert Opin. Drug Deliv. Bilensoy 6 1161 2009 10.1517/17425240903222218 Recent advances and future directions in amphiphilic cyclodextrin nanoparticles 

  111. Int. J. Pharm. Skiba 142 121 1996 10.1016/0378-5173(96)04653-4 Characterization of amphiphilic β-cyclodextrin nanospheres 

  112. Int. J. Pharm. Skiba 129 113 1996 10.1016/0378-5173(95)04272-5 Development of a new colloidal drug carrier from chemically-modified cyclodextrins: nanospheres and influence of physicochemical and technological factors on particle size 

  113. Pharm. Res. Memisoglu 20 117 2003 10.1023/A:1022263111961 Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes 

  114. Eur. J. Pharm. Biopharm. Yameogo 80 508 2012 10.1016/j.ejpb.2011.12.007 Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers-I: formulation, lyoavailability and in vitro antimalarial activity assessment 

  115. Biomaterials Sortino 27 4256 2006 10.1016/j.biomaterials.2006.03.035 Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer system in photodynamic cancer therapy 

  116. Chem. Eur. J. Kandoth 18 1684 2012 10.1002/chem.201101635 A cyclodextrin-based nanoassembly with bimodal photodynamic action 

  117. Polym. Chem. Thiele 2 209 2011 10.1039/C0PY00241K Nanoparticles of anionic starch and cationic cyclodextrin derivatives for the targeted delivery of drugs 

  118. Eur. J. Pharm. Sci. Kang 15 163 2002 10.1016/S0928-0987(01)00214-7 Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent 

  119. Cancer Chemother. Pharmacol. Schluep 2006 654 2005 Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice 

  120. Clin. Cancer Res. Schluep 12 1606 2006 10.1158/1078-0432.CCR-05-1566 Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models 

  121. J. Control. Release Svenson 153 49 2011 10.1016/j.jconrel.2011.03.007 Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101 

  122. Proc. Natl. Acad. Sci. U. S. A. Schluep 106 11394 2009 10.1073/pnas.0905487106 Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements 

  123. Clin. Cancer Res. Schluep 15 181 2009 10.1158/1078-0432.CCR-08-1848 Polymeric tubulysin-peptide nanoparticles with potent antitumor activity 

  124. J. Control. Release Zhang 145 116 2010 10.1016/j.jconrel.2010.04.019 Hydrophobic pharmaceuticals mediated self-assembly of beta-cyclodextrin containing hydrophilic copolymers: novel chemical responsive nano-vehicles for drug delivery 

  125. Polymer Zhang 52 4928 2010 10.1016/j.polymer.2011.08.030 Core-shell structured nanoassemblies based on β-cyclodextrin containing block copolymer and poly(β-benzyl l-aspartate) via host-guest complexation 

  126. Prog. Polym. Sci. Rapoport 32 962 2007 10.1016/j.progpolymsci.2007.05.009 Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery 

  127. Adv. Drug Deliv. Rev. Bae 61 768 2009 10.1016/j.addr.2009.04.016 Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers 

  128. Acc. Chem. Res. Cabral 44 999 2011 10.1021/ar200094a Supramolecular nanodevices: from design validation to theranostic nanomedicine 

  129. Eur. Polym. J. Layre 45 3016 2009 10.1016/j.eurpolymj.2009.08.007 Tuning the interactions in cyclodextrin polymer nanoassemblies 

  130. Angew. Chem. Int. Ed. Dong 47 5573 2008 10.1002/anie.200800952 A facile one-pot construction of supramolecular polymer micelles from α-cyclodextrin and poly(e-caprolactone) 

  131. Carbohydr. Polym. Li 86 120 2011 10.1016/j.carbpol.2011.04.017 Self-assembly of carboxymethyl konjac glucomannan-g-poly(ethylene glycol) and (a-cyclodextrin) to biocompatible hollow nanospheres for glucose oxidase encapsulation 

  132. Soft Matter Liu 7 662 2011 10.1039/C0SM00708K Biocompatible vesicles based on PEO-b-PMPC/α-cyclodextrin inclusion complexes for drug delivery 

  133. Langmuir Liu 23 5106 2007 10.1021/la063365r Alpha-cyclodextrin-induced self-assembly of a double-hydrophilic block copolymer in aqueous solution 

  134. Polymer Liu 50 855 2009 10.1016/j.polymer.2008.12.005 Chaperone-like a-cyclodextrins assisted self-assembly of double hydrophilic block copolymers in aqueous medium 

  135. Pharm. Res. Croyle 15 1348 1998 10.1023/A:1011985101580 Beta-cyclodextrins enhance adenoviral-mediated gene delivery to the intestine 

  136. Adv. Drug Deliv. Rev. Redenti 53 235 2001 10.1016/S0169-409X(01)00230-7 Cyclodextrins in oligonucleotide delivery 

  137. PNAS Jessel 103 8618 2006 10.1073/pnas.0508246103 Multiple and time-scheduled in situ DNA delivery mediated by β-cyclodextrin embedded in a polyelectrolyte multilayer 

  138. Eur. J. Pharm. Sci. Cryan 21 625 2004 10.1016/j.ejps.2004.01.001 Cell transfection with polycationic cyclodextrin vectors 

  139. Bioconjugate Chem. Arima 12 476 2001 10.1021/bc000111n Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins 

  140. Bioconjugate Chem. Menuel 19 2357 2008 10.1021/bc800193p Synthesis and complexation ability of a novel bis-(guanidinium)-tetrakis-(β-cyclodextrin) dendrimeric tetrapod as a potential gene delivery (DNA and siRNA) system. Study of cellular siRNA transfection 

  141. J. Control. Release Tsutsumi 119 349 2007 10.1016/j.jconrel.2007.03.013 Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA) 

  142. Biotechnol. Bioeng. Forrest 89 416 2005 10.1002/bit.20356 Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery 

  143. ChemBioChem Choi 6 1986 2005 10.1002/cbic.200500242 Sunflower-shaped cyclodextrin-conjugated poly(ε-lysine) polyplex as a controlled intracellular trafficking device 

  144. Chem. Soc. Rev. Harada 38 875 2009 10.1039/b705458k Cyclodextrin-based supramolecular polymers 

  145. Macromolecules Choi 37 6705 2004 10.1021/ma049215+ pH dependence of polypseudorotaxane formation between cationic linear polyethylenimine and cyclodextrins 

  146. ChemBioChem Yamashita 7 297 2006 10.1002/cbic.200500348 Improved cell viability of linear polyethylenimine through γ-cyclodextrin inclusion for effective gene delivery 

  147. J. Am. Chem. Soc. Ooya 128 3852 2006 10.1021/ja055868+ Biocleavable polyrotaxane-plasmid DNA polyplex for enhanced gene delivery 

  148. Adv. Mater. Li 18 2969 2006 10.1002/adma.200600812 Cationic supramolecules composed of multiple oligoethylenimine-grafted b-cyclodextrins threaded on a polymer chain for efficient gene delivery 

  149. J. Am. Chem. Soc. Liu 129 10656 2007 10.1021/ja073882b Construction and DNA condensation of cyclodextrin-based polypseudorotaxanes with anthryl grafts 

  150. Bioconjugate Chem. Burckbuchler 19 2311 2008 10.1021/bc800070f Development and characterization of new cyclodextrin polymer-based DNA delivery systems 

  151. Chem. Commun. Diaz-Moscoso 2001 2008 10.1039/b718672j Rational design of cationic cyclooligosaccharides as efficient gene delivery systems 

  152. Bioconjugate Chem. Hwang 12 280 2001 10.1021/bc0001084 Effects of structure of α-cyclodextrin-containing polymers on gene delivery 

  153. Bioconjugate Chem. Reineke 14 247 2003 10.1021/bc025592k Structural effects of carbohydrate-containing polycations on gene delivery. 1. Carbohydrate size and its distance from charge centers 

  154. Bioconjugate Chem. Reineke 14 255 2003 10.1021/bc025593c Structural effects of carbohydrate-containing polycations on gene delivery. 2. Charge center type 

  155. Bioconjugate Chem. Bartlett 18 456 2007 10.1021/bc0603539 Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles 

  156. Cancer Biol. Ther. Pun 3 641 2004 10.4161/cbt.3.7.918 Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles 

  157. Cancer Res. Hu-Lieskovan 65 8984 2005 10.1158/0008-5472.CAN-05-0565 Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma 

  158. Proc. Natl. Acad. Sci. U. S. A. Heidel 104 5715 2007 10.1073/pnas.0701458104 Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA 

  159. Nature Davis 464 1067 2010 10.1038/nature08956 Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles 

  160. Pharmacol. Rev. Greco 47 331 1995 The search for synergy: a critical review from a response surface perspective 

  161. Ther. Deliv. Hu 1 323 2010 10.4155/tde.10.13 Nanoparticle-assisted combination therapies for effective cancer treatment 

  162. Nat. Biotechnol. Rebuffat 19 1155 2001 10.1038/nbt1201-1155 Selective enhancement of gene transfer by steroid-mediated gene delivery 

  163. FASEB J. Liu 18 1779 2004 10.1096/fj.04-2187fje Nonimmunostimulatory nonviral vectors 

  164. Nat. Mater. Wang 5 791 2006 10.1038/nmat1737 Codelivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer 

  165. ACS Nano Zhang 4 1049 2010 10.1021/nn901213a Host-guest interactions mediated polymeric assemblies: multifunctional nanoparticles for drug and gene delivery 

  166. J. Pharm. Pharm. Sci. Wu 10 350 2007 Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil 

  167. Nanomedicine Saad 3 761 2008 10.2217/17435889.3.6.761 Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer 

  168. Biomaterials Fan 33 1428 2012 10.1016/j.biomaterials.2011.10.043 In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL 

  169. J. Am. Chem. Soc. Takae 130 6001 2008 10.1021/ja800336v PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors 

  170. Bioconjugate Chem. Tang 20 1095 2009 10.1021/bc900144m Shell-detachable micelles based on disulfide-linked block copolymer as potential carrier for intracellular drug delivery 

  171. Soft Matter Zhang 6 610 2010 10.1039/B913608H Spontaneous formation of temperature-responsive assemblies by molecular recognition of a β-cyclodextrin containing block copolymer and poly(N-isopropylacrylamide) 

  172. Angew. Chem. Int. Ed. Ravoo 39 4324 2000 10.1002/1521-3773(20001201)39:23<4324::AID-ANIE4324>3.0.CO;2-O Cyclodextrin bilayer vesicles 

  173. Chem. Eur. J. Falvey 11 1171 2005 10.1002/chem.200400905 Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules 

  174. J. Am. Chem. Soc. Versluis 131 13186 2009 10.1021/ja9026264 Shape and release control of a peptide decorated vesicle through pH sensitive orthogonal supramolecular interactions 

  175. Prog. Polym. Sci. Zhang 37 1130 2012 10.1016/j.progpolymsci.2011.11.005 Stimuli-triggered structural engineering of synthetic and biological polymeric assemblies 

  176. Chem. Asian J. Deng 3 687 2008 10.1002/asia.200700378 Construction of chemical-responsive supramolecular hydrogels from guest-modified cyclodextrins 

  177. NPG Asia Mater. Li 2 112 2010 10.1038/asiamat.2010.84 Self-assembled supramolecular hydrogels based on polymer-cyclodextrin inclusion complexes for drug delivery 

  178. Nat. Chem. Harada 3 34 2011 10.1038/nchem.893 Macroscopic self-assembly through molecular recognition 

  179. Nat. Commun. Yamaguchi 3 1 2012 10.1038/ncomms1617 Photoswitchable gel assembly based on molecular recognition 

  180. Nat. Commun. Nakahata 2 1 2011 10.1038/ncomms1521 Redox-responsive self-healing materials formed from host−guest polymers 

  181. Polym. J. Li 26 1019 1994 10.1295/polymj.26.1019 Sol-gel transition during inclusion complex formation between a-cyclodextrin and high molecular weight poly(ethylene glycol)s in aqueous solution 

  182. Eur. J. Pharm. Biopharm. Nogueiras-Nieto 80 585 2012 10.1016/j.ejpb.2011.12.001 Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery 

  183. Adv. Funct. Mater. Chen 20 579 2010 10.1002/adfm.200901400 Dual stimuli-responsive supramolecular polypeptide-based hydrogel and reverse micellar hydrogel mediated by host-guest chemistry 

  184. Soft Matter Yu 7 7386 2011 10.1039/c1sm05426k Fabrication and evaluation of reduction-sensitive supramolecular hydrogel based on cyclodextrin/polymer inclusion for injectable drug-carrier application 

  185. Angew. Chem. Int. Ed. Liao 49 4409 2010 10.1002/anie.201000141 Photoresponsive pseudopolyrotaxane hydrogels based on competition of host-guest interactions 

  186. J. Biomed. Mater. Res. Li 65A 196 2003 10.1002/jbm.a.10444 Injectable drug-delivery systems based on supramolecular hydrogels formed by poly(ethylene oxide)s and α-cyclodextrin 

  187. Int. J. Pharm. Hashim 392 83 2010 10.1016/j.ijpharm.2010.03.026 Potential use of γ-cyclodextrin polypseudorotaxane hydrogels as an injectable sustained release system for insulin 

  188. J. Colloid Interface Sci. Ma 359 399 2011 10.1016/j.jcis.2011.04.032 Tunable supramolecular hydrogel for in situ encapsulation and sustained release of bioactive lysozyme 

  189. Eur. J. Pharm. Biopharm. Simoes 89 103 2012 10.1016/j.ejpb.2011.09.017 Syringeable Pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin 

  190. Biomacromolecules Ma 11 2204 2010 10.1021/bm100676a Bioactive supramolecular hydrogel with controlled dual drug release characteristics 

  191. Biomacromolecules Ma 12 3124 2011 10.1021/bm101566r Supramolecular gelation of a polymeric prodrug for its encapsulation and sustained release 

  192. Nat. Rev. Drug Discov. Harris 2 214 2003 10.1038/nrd1033 Effect of pegylation on pharmaceuticals 

  193. Macromolecules Auzely-Velty 35 7955 2002 10.1021/ma020664o New supramolecular assemblies of a cyclodextrin-grafted chitosan through specific complexation 

  194. Macromolecules van de Manakker 41 1766 2008 10.1021/ma702607r Self-assembling hydrogels based on β-cyclodextrin/cholesterol inclusion complexes 

  195. Adv. Funct. Mater. van de Manakker 19 2992 2009 10.1002/adfm.200900603 Protein-release behavior of self-assembled PEG-β-cyclodextrin/PEG-cholesterol hydrogels 

  196. Soft Matter van de Manakker 6 187 2010 10.1039/B916378F Supramolecular hydrogels formed by β-cyclodextrin self-association and host-guest inclusion complexes 

  197. Chem. Commun. Peng 46 4094 2010 10.1039/c002565h Light controlled protein release from a supramolecular hydrogel 

  198. Angew. Chem. Int. Ed. Tamesue 49 7461 2010 10.1002/anie.201003567 Photoswitchable supramolecular hydrogels formed by cyclodextrins and azobenzene polymers 

  199. J. Phys. Chem. C Li 115 17651 2011 10.1021/jp203940s Host-guest assembly of pH-responsive degradable microcapsules with controlled drug release behavior 

  200. J. Phys. Chem. B Xiao 115 13796 2011 10.1021/jp208692c Design of a photoswitchable hollow microcapsular drug delivery system by using a supramolecular drug-loading approach 

  201. Macromol. Biosci. Wintgens 11 1254 2011 10.1002/mabi.201100097 Size-controlled nanoassemblies based on cyclodextrin-modified dextrans 

  202. Macromol. Chem. Phys. Bohm 212 1080 2011 10.1002/macp.201100006 Stimuli responsive size control of hyperbranched polymers 

  203. Angew. Chem. Int. Ed. Bohm 50 7896 2011 10.1002/anie.201101604 Cyclodextrin and adamantane host-guest interactions of modified hyperbranched poly(ethylene imine) as mimetics for biological membranes 

  204. Macromol. Chem. Phys. Bohm 213 243 2012 10.1002/macp.201100259 Switchable supramolecular crosslinking of cyclodextrin-modified hyperbranched polyethylenimine via anthraquinone dyes 

  205. Acta Biomater. Zhang 7 585 2011 10.1016/j.actbio.2010.08.029 A hydrotropic β-cyclodextrin grafted hyperbranched polyglycerol co-polymer for hydrophobic drug delivery 

  206. Carbohydr. Polym. Zhang 84 1419 2011 10.1016/j.carbpol.2011.01.057 β-Cyclodextrin grafting hyperbranched polyglycerols as carriers for nasal insulin delivery 

  207. Macromolecules Yhaya 44 8433 2011 10.1021/ma2013964 Development of micellar novel drug carrier utilizing temperature-sensitive block copolymers containing cyclodextrin moieties 

  208. J. Appl. Polym. Sci. Chen 82 2414 2001 10.1002/app.2092 Study on β-cyclodextrin grafting with chitosan and slow release of its inclusion complex with radioactive iodine 

  209. Macromol. Biosci. Prabaharan 5 965 2005 10.1002/mabi.200500087 Hydroxypropyl chitosan bearing β-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug 

  210. Carbohydr. Polym. Prabaharan 73 117 2008 10.1016/j.carbpol.2007.11.005 Novel thiolated carboxymethyl chitosan-g-β-cyclodextrin as mucoadhesive hydrophobic drug delivery carriers 

  211. J. Am. Chem. Soc. Liu 130 10431 2008 10.1021/ja802465g Supramolecular architectures of β-cyclodextrin-modified chitosan and pyrene derivatives mediated by carbon nanotubes and their DNA condensation 

  212. J. Incl. Phenom. Macrocycl. Chem. Huang 72 55 2012 10.1007/s10847-011-9938-1 Synthesis of conjugates of β-cyclodextrin with polyamidoamine dendrimers and their molecular inclusion interaction with levofloxacin lactate 

  213. J. Control. Release Zhu 152 317 2011 10.1016/j.jconrel.2011.03.013 Highly efficient nanomedicines assembled via polymer-drug multiple interactions: tissue-selective delivery carriers 

  214. Bioconjugate Chem. Pun 15 831 2004 10.1021/bc049891g Cyclodextrin-modified polyethylenimine polymers for gene delivery 

  215. Angew. Chem. Int. Ed. Wang 48 4344 2009 10.1002/anie.200900063 A supramolecular approach for preparation of size-controlled nanoparticles 

  216. Bioconjugate Chem. Chen 22 1162 2011 10.1021/bc200010w Photoluminescent hyperbranched poly(amido amine) containing β-cyclodextrin as a nonviral gene delivery vector 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로